Patents by Inventor Ju Gao

Ju Gao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050277638
    Abstract: The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    Type: Application
    Filed: December 22, 2004
    Publication date: December 15, 2005
    Inventors: Andrew Souers, Christine Collins, Ju Gao, Andrew Judd, Philip Kym, Mathew Mulhern, Hing Sham, Dariusz Wodka
  • Publication number: 20050269953
    Abstract: The invention is directed to a method and apparatus for phase-locking microdischarge device arrays and an ac, rf, or pulse-excited microdischarge. The invention provides output from a non-laser optical source that is a phase-locked array of microdischarges formed of microdischarge cavities containing discharge filler and excitation electrodes. In exemplary embodiments, entire arrays of microdischarge device optical emitters that are not lasers can be fabricated into a surface area having a largest dimension smaller than the coherence length of at least one of the emissions produced by the individual elements. In other embodiments, arrays of microdischarge devices configured in a Fresnel pattern constitute a lens suitable for both producing and focusing light.
    Type: Application
    Filed: April 22, 2004
    Publication date: December 8, 2005
    Inventors: J. Eden, Ju Gao, Sung-o Kim
  • Publication number: 20050218814
    Abstract: A method of generating an electrical discharge in a gas contained in a sealed enclosure. The method includes driving a helical coil resonator at an RF frequency to generate an RF electric-magnetic field sufficient to generate an electrical discharge in the high pressure gas. The electrical discharge produces an emission spectrum that may be spectroscopically analyzed to determine the composition and impurity content of the gas.
    Type: Application
    Filed: March 18, 2005
    Publication date: October 6, 2005
    Inventors: Ju Gao, Joseph Verdeyen
  • Publication number: 20050209274
    Abstract: The present invention is directed to compounds of formula (I), which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    Type: Application
    Filed: February 25, 2005
    Publication date: September 22, 2005
    Inventors: John Lynch, Christine Collins, Jennifer Freeman, Ju Gao, Rajesh Iyengar, Andrew Judd, Philip Kym, Mathew Mulhern, Hing Sham, Andrew Souers, Gang Zhao, Dariusz Wodka
  • Publication number: 20050187279
    Abstract: The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    Type: Application
    Filed: December 22, 2004
    Publication date: August 25, 2005
    Inventors: Andrew Souers, Christine Collins, Ju Gao, Andrew Judd, Philip Kym, Mathew Mulhern, Hing Sham, Dariusz Wodka
  • Publication number: 20050187387
    Abstract: The present invention is directed to compounds of formula (I), which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    Type: Application
    Filed: February 25, 2004
    Publication date: August 25, 2005
    Inventors: John Lynch, Christine Collins, Jennifer Freeman, Ju Gao, Rajesh Iyengar, Andrew Judd, Philip Kym, Mathew Mulhern, Hing Sham, Andrew Souers, Gang Zhao
  • Publication number: 20050171421
    Abstract: A detector uses the magneto-optical Kerr effect and exploits the transition region between two magnetization states of a magneto-optical film to detect magnetic fields of less than 100 pT. The magnetic field of a subject is determined by examining the polarization of light reflected from the magneto-optical film. A several ?m thick, bismuth doped, YIG film is used for detection as the transition regions are steep, providing large changes in the polarization rotation angle for small variations in the applied magnetic field. The apparatus may be used in the functional imaging of various organs and systems in humans and animals or for the spatial and temporal tracking of nano or micro magnetic particles intentionally introduced into the circulatory or intestinal systems for diagnostic or research purposes.
    Type: Application
    Filed: January 20, 2004
    Publication date: August 4, 2005
    Inventors: J Eden, Ju Gao
  • Patent number: 6921821
    Abstract: This invention provides compounds that are antagonists of melanin concentrating hormone receptor-1 (MCH-R1). The compounds are represented by formula I: where m is zero or one, n is zero to two, Y is oxygen or —N(R9)—, R1, R2, R3, R4, R5, R9 and Ring A are defined in the specification. Coumarin and quinolone compounds where R1 and R2 together form a fused benzo ring are preferred. The invention also provides compounds of formula VI where the coumarin moiety is replaced by a quinazolinone ring. The compounds are useful for treating MCH-R1-related disorders, particularly overweight conditions including obesity.
    Type: Grant
    Filed: June 11, 2003
    Date of Patent: July 26, 2005
    Assignee: Abbott Laboratories
    Inventors: Christopher Blackburn, Su-Jen Lai, Jennifer L. Che, Martin P. Maguire, Michael A. Patane, Matthew J. LaMarche, Courtney A. Cullis, James Brown, Anil Vasudevan, Jennifer C. Freeman, Mathew M. Mulhern, John K. Lynch, Ju Gao, Dariusz Wodka, Andrew J. Souers, Rajesh Iyengar, Mary Katherin Verzal, Philip R. Kym
  • Publication number: 20050137187
    Abstract: The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    Type: Application
    Filed: December 23, 2003
    Publication date: June 23, 2005
    Inventors: Andrew Souers, Christine Collins, Ju Gao, Andrew Judd, Philip Kym, Mathew Mulhern, Hing Sham, Dariusz Wodka
  • Publication number: 20050137243
    Abstract: The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    Type: Application
    Filed: December 23, 2003
    Publication date: June 23, 2005
    Inventors: Andrew Souers, Christine Collins, Ju Gao, Andrew Judd, Philip Kym, Mathew Mulhern, Hing Sham, Anil Vasudevan, Dariusz Wodka
  • Publication number: 20050093481
    Abstract: A method of generating an electrical discharge in a high pressure gas contained in a sealed enclosure. The method includes driving a helical coil resonator at an RF frequency to generate an RF electric-magnetic field sufficient to generate an electrical discharge in the high pressure gas. The electrical discharge produces an emission spectrum that may be spectroscopically analyzed to determine the composition and impurity content of the gas.
    Type: Application
    Filed: September 14, 2004
    Publication date: May 5, 2005
    Inventors: Ju Gao, Joseph Verdeyen
  • Publication number: 20050094940
    Abstract: An optical system and method including an integrated light source and optical waveguide that relies on internal reflection for coupling the light emitted from the source to the waveguide. The light source may include electroded or electrodeless plasma lamps, LEDs, and filament lamps. The optical waveguide may be shaped to form a compound parabolic waveguide. A system may also include an integrated light source, microwave waveguide, and optical coupler.
    Type: Application
    Filed: September 27, 2004
    Publication date: May 5, 2005
    Inventor: Ju Gao
  • Patent number: 6818772
    Abstract: The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: November 16, 2004
    Assignee: Abbott Laboratories
    Inventors: Philip R. Kym, Kresna Hartandi, Ju Gao, Kathleen M. Phelan, Irini Akritopoulou-Zanze, Christine A. Collins, Anil Vasudevan, Mary K. Verzal
  • Patent number: 6818918
    Abstract: A Josephson junction includes first and second electrodes, each of which is formed of superconductive material. The first electrode has a first electrode face. A barrier of the junction extends from the first electrode to the second electrode. The barrier has a first barrier face opposing and adjoining the first electrode face. The barrier is formed of non-superconductive barrier material and superconductive barrier material. A concentration of the superconductive barrier material is greater than zero at the first barrier face, whereby the first barrier face is formed at least partially of the superconductive barrier material.
    Type: Grant
    Filed: November 5, 2001
    Date of Patent: November 16, 2004
    Assignee: The University of Hong Kong
    Inventors: Ju Gao, Jinglan Sun
  • Patent number: 6791280
    Abstract: A method of generating an electrical discharge in a high pressure gas contained in a sealed enclosure. The method includes driving a helical coil resonator at an RF frequency to generate an RF electric-magnetic field sufficient to generate an electrical discharge in the high pressure gas. The electrical discharge produces an emission spectrum that may be spectroscopically analyzed to determine the composition and impurity content of the gas.
    Type: Grant
    Filed: April 1, 2002
    Date of Patent: September 14, 2004
    Assignee: Advanced Lighting Technologies, Inc.
    Inventors: Ju Gao, Joseph T. Verdeyen
  • Publication number: 20040106645
    Abstract: This invention provides compounds that are antagonists of melanin concentrating hormone receptor-1 (MCH-R1).
    Type: Application
    Filed: June 11, 2003
    Publication date: June 3, 2004
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Christopher Blackburn, Su-Jen Lai, Jennifer L. Che, Martin P. Maguire, Michael A. Patane, Matthew J. LaMarche, Courtney A. Cullis, James Brown, Anil Vasudevan, Jennifer C. Freeman, Mathew M. Mulhern, John K. Lynch, Ju Gao, Dariusz Wodka, Andrew J. Souers, Rajesh Iyengar, Mary Katherin Verzal, Philip R. Kym
  • Publication number: 20040063756
    Abstract: The present invention is related to compounds of formula (I), 1
    Type: Application
    Filed: June 12, 2003
    Publication date: April 1, 2004
    Inventors: Christine A. Collins, Ju Gao, Philip R. Kym, Jared C. Lewis, Andrew J. Souers, Anil Vasudevan, Dariusz Wodka
  • Publication number: 20030229119
    Abstract: The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    Type: Application
    Filed: February 21, 2003
    Publication date: December 11, 2003
    Inventors: Philip R. Kym, Kresna Hartandi, Ju Gao, Kathleen M. Phelan, Irini Akritopoulou-Zanze, Christine A. Collins, Anil Vasudevan, Mary K. Verzal
  • Patent number: 6541915
    Abstract: Start-up and re-ignition of a high pressure arc lamp are aided by injection of electrons toward a high pressure arc lamp electrode. A microdischarge device directs electrons toward an electrode of the arc lamp and is preferably turned off during normal operation of the arc lamp. The harsh environment of an arc lamp requires the microdischarge to be made from robust materials, such as ceramics, semiconductors or tungsten, for example. In the present invention, the discharge design must allow, preferably through a screen anode, for the escape of electrons from the microdischarge. This invention results in a decrease in the voltage required to start-up or re-ignite a lamp.
    Type: Grant
    Filed: July 23, 2001
    Date of Patent: April 1, 2003
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: James Gary Eden, Ju Gao, Sung-Jin Park, Clark J. Wagner
  • Publication number: 20030015969
    Abstract: Start-up and re-ignition of a high pressure arc lamp are aided by injection of electrons toward a high pressure arc lamp electrode. A microdischarge device directs electrons toward an electrode of the arc lamp and is preferably turned off during normal operation of the arc lamp. The harsh environment of an arc lamp requires the microdischarge to be made from robust materials, such as ceramics, semiconductors or tungsten, for example. In the present invention, the discharge design must allow, preferably through a screen anode, for the escape of electrons from the microdischarge. This invention results in a decrease in the voltage required to start-up or re-ignite a lamp.
    Type: Application
    Filed: July 23, 2001
    Publication date: January 23, 2003
    Inventors: J. G. Eden, Ju Gao, S. J. Park, C. J. Wagner